SCHEMBL4440066

SCHEMBL4440066

CCC(=O)Nc1ccc(OCc2ccc(Cl)cc2C(F)(F)F)cc1C(=O)O.CCC(=O)Nc1ccc(OCc2ccc(F)cc2Cl)cc1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
ALDH1A1 P00352 3/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NR4A2 P43354 2/20 0.43
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.41
ADAMTS4 O75173 1/20 0.41
MMP2 P08253 1/20 0.41
MMP13 P45452 1/20 0.41
MMP14 P50281 1/20 0.41
ADAMTS5 Q9UNA0 1/20 0.41
NR4A1 P22736 1/20 0.41
NR4A3 Q92570 1/20 0.41
POLB P06746 2/20 0.40
PPARG P37231 2/20 0.40
SCN9A Q15858 1/20 0.40
SLC26A4 O43511 1/20 0.40
FABP3 P05413 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1827458 0.93 KDM4E (0.51) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL1827139 0.90 PPARD (0.43) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL1823452 0.90 ADAMTS4 (0.48) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL1825956 0.86 NR4A2 (0.57) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL1822953 0.83 MRGPRX4 (0.49) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL1827618 0.82 SRD5A2 (0.47) KDM4EALDH1A1MAPT
SCHEMBL4441436 0.82 PTGER1 (0.39) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL1826022 0.82 KDM4E (0.54) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL1826874 0.81 KMT2A (0.49) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL4604582 0.80 MAOB (0.53) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118051-A1 NEW COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF Chelsea Therapeutics, Inc. (US) 2009-11-18 EP claimed
WO-2008097180-A1 NEW COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF CHELSEA THERAPEUTICS, INC. (US) 2008-08-14 WO claimed